Messenger RNA

Sep 25, 2017

eTheRNA immunotherapies Awarded EUR1 Million Grant From Flanders Innovation & Entrepreneurship to Further Upgrade its State-of-the-art Production Process for TriMix mRNA Immunotherapies

Sep 12, 2017

The 5th International mRNA Health Conference to Showcase Advances in mRNA Cancer Therapy, Antibody Development and Vaccines

Aug 15, 2017

Publication in EMBO Molecular Medicine Demonstrates CureVac's Proprietary mRNA Technology Enables Antibody Mediated Therapies Against Infectious Agents, Toxins and Tumors

Aug 10, 2017

mRNA Vaccines & Therapeutics Markets 2017: Technologies, Pipelines, Stakeholders and Deals Report - Market have Attracted US$ 3.4+ Billion in Equity Financing and Frontloaded Partnership Payments

Jul 31, 2017

The 5th International mRNA Health Conference to Showcase Tremendous Advances in the Development of mRNA Drugs

Jul 26, 2017

CureVac Announces Publication in The Lancet of First-Ever Human Proof-of-Concept Study Investigating the Safety and Immunogenicity of a Prophylactic mRNA Vaccine

Jun 26, 2017

CureVac Expands GMP Production Capacities for RNA Products

Jun 13, 2017

CureVac Extends Global Intellectual Property Estate for Prophylactic mRNA Vaccines